Morocco’s T2S Group Ready for $120 Million IPO on Casablanca Stock Exchange
Moroccan medical technology specialist T2S Group Holding is preparing to launch a $120 million Initial Public Offering (IPO). This strategic move is aimed at funding the company's aggressive expansion plans both within Morocco and across international markets, while solidifying its presence in the healthcare technology sector.
The company has secured regulatory approval to list its shares, with the subscription period scheduled to run from July 13 to July 17, and the share price set at approximately $24. This milestone marks the first new listing on the Casablanca Stock Exchange in 2026, arriving at a time when the Kingdom is actively working to revitalize its capital markets and increase the number of publicly traded entities.
Sourcing Fresh Capital for Growth
The IPO structure is split between a capital increase of approximately $37.4 million through the issuance of new shares and the sale of existing shares valued at around $80.1 million. This dual approach provides the company with immediate liquidity to fund future investments, expands its shareholder base, and enhances its long-term access to new financing pipelines.
With over 35 years of experience in the med-tech sector, T2S provides a wide array of integrated solutions. These encompass medical imaging and diagnostic equipment, oncology treatments, operating theater outfitting, medical supplies, laboratory diagnostics, the production and distribution of radiopharmaceuticals, and digital health software.
Robust Financial Projections
The company's financial indicators reflect highly ambitious growth targets for the coming years:
Revenue Dynamics: T2S registered a revenue of approximately $182 million in 2025. It forecasts a 21% growth during the current year and aims to reach $438 million by 2030—marking a stellar 136% surge compared to 2025 levels.
Net Profits: Net income stood at roughly $22.5 million in 2025, and is projected to rise to $25.1 million in 2026, before hitting approximately $64.9 million by the end of the decade—a total growth of nearly 187%.
Shareholding Structure and Public Float
Prior to the offering, the British investment fund Trone Investment Holdings held the majority stake at 62%, which is expected to adjust to 42% post-capital increase. The company's original founders, led by Abderraouf Sordo, will retain a stake of approximately 20%.
Following the listing, the free-floating shares will account for 22.6% of the company's capital. Notably, 36.4% of the IPO shares have been allocated specifically to retail investors with no minimum subscription limit, while the remaining portion is designated for institutional investors.
This landmark listing coincides with Morocco's comprehensive broader economic push to enhance the attractiveness of its financial markets through regulatory reforms designed to encourage initial public offerings. The Kingdom has set a clear target to scale the number of listed companies on its stock exchange to 300 over the next decade, up from the current pool of roughly 80 companies, which currently hold a combined market capitalization exceeding $111 billion.